Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nong Yang

Showing results (51-60 of 208) with videos related to

Pageof 21
Sort By:
Frontiers in Pharmacology|May 28, 2020
Polymorphisms of Drug-Metabolizing Enzymes and Transporters Contribute to the Individual Variations of Erlotinib Steady State Trough Concentration, Treatment Outcomes, and Adverse Reactions in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer PatientsDehua Liao, Zhigang Liu, Yongchang Zhang, et al.
Frontiers in Oncology|December 26, 2024
Octreotide plus IBI-318 plus anlotinib in the treatment of multiple neuroendocrine metastases of unknown primary lesions: a case reportHaoyue Qin, Huan Yan, Xing Zhang, et al.
Radiation Research|September 20, 2016
PIDD Mediates Radiation-Induced Microglia ActivationNong Yang, Xican Gao, Xiaofei Qu, et al.
Translational Cancer Research|February 4, 2022
The clinical significance of RET gene fusion among Chinese patients with lung cancerPuyuan Xing, Nong Yang, Xue Hu, et al.
Clinical Lung Cancer|September 11, 2018
Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung CancerFang Wu, Xiaoping Lin, Zhanghuan Yang, et al.
Chinese Medical Journal|May 17, 2023
Intracranial activity of first-line immune checkpoint inhibitors combined with chemotherapy in advanced non-small cell lung cancerZhe Huang, Fang Wu, Qinqin Xu, et al.
Micromachines|February 21, 2019
A Microfluidic Micropipette Aspiration Device to Study Single-Cell Mechanics Inspired by the Principle of Wheatstone BridgeYong-Jiang Li, Yu-Nong Yang, Hai-Jun Zhang, et al.
Oncotargets and Therapy|November 10, 2018
Crizotinib presented with promising efficacy but for concomitant mutation in next-generation sequencing-identified ROS1-rearranged non-small-cell lung cancerLiang Zeng, Yizhi Li, Lili Xiao, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2021
Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective studyWenxian Wang, Chunwei Xu, Huafei Chen, et al.
Iranian Journal of Pharmaceutical Research : IJPR|March 8, 2021
A Randomized, Open, Single-Centre, Crossed Study of the Effect of Food on the Pharmacokinetics of One Oral Dose of Alflutinib Mesylate Tablets (AST2818) in Healthy Male SubjectsSonglin Zhu, Jun Deng, Qi Tang, et al.
Pageof 21

Showing results (51-60 of 208) with videos related to

Sort By:
Pageof 21
Frontiers in Pharmacology|May 28, 2020
Polymorphisms of Drug-Metabolizing Enzymes and Transporters Contribute to the Individual Variations of Erlotinib Steady State Trough Concentration, Treatment Outcomes, and Adverse Reactions in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer PatientsDehua Liao, Zhigang Liu, Yongchang Zhang, et al.
Frontiers in Oncology|December 26, 2024
Octreotide plus IBI-318 plus anlotinib in the treatment of multiple neuroendocrine metastases of unknown primary lesions: a case reportHaoyue Qin, Huan Yan, Xing Zhang, et al.
Radiation Research|September 20, 2016
PIDD Mediates Radiation-Induced Microglia ActivationNong Yang, Xican Gao, Xiaofei Qu, et al.
Translational Cancer Research|February 4, 2022
The clinical significance of RET gene fusion among Chinese patients with lung cancerPuyuan Xing, Nong Yang, Xue Hu, et al.
Clinical Lung Cancer|September 11, 2018
Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung CancerFang Wu, Xiaoping Lin, Zhanghuan Yang, et al.
Chinese Medical Journal|May 17, 2023
Intracranial activity of first-line immune checkpoint inhibitors combined with chemotherapy in advanced non-small cell lung cancerZhe Huang, Fang Wu, Qinqin Xu, et al.
Micromachines|February 21, 2019
A Microfluidic Micropipette Aspiration Device to Study Single-Cell Mechanics Inspired by the Principle of Wheatstone BridgeYong-Jiang Li, Yu-Nong Yang, Hai-Jun Zhang, et al.
Oncotargets and Therapy|November 10, 2018
Crizotinib presented with promising efficacy but for concomitant mutation in next-generation sequencing-identified ROS1-rearranged non-small-cell lung cancerLiang Zeng, Yizhi Li, Lili Xiao, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2021
Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective studyWenxian Wang, Chunwei Xu, Huafei Chen, et al.
Iranian Journal of Pharmaceutical Research : IJPR|March 8, 2021
A Randomized, Open, Single-Centre, Crossed Study of the Effect of Food on the Pharmacokinetics of One Oral Dose of Alflutinib Mesylate Tablets (AST2818) in Healthy Male SubjectsSonglin Zhu, Jun Deng, Qi Tang, et al.
Pageof 21